Subscribe200$/product give away!

Submit an Article to Pharmacy HQ     
Please include the author's name, title, and citations.     

ELAPRASE- idursulfase solution, concentrate

  1. Patient Information
  2. Elaprase Is Manufactured By:

Patient Information 

Information for Patients

Patients should be advised that life-threatening anaphylactic reactions have occurred in some patients during and up to 24 hours after ELAPRASE therapy. Patients who have experienced anaphylactic reactions may require prolonged observation. Patients with compromised respiratory function or acute respiratory disease may be at risk of serious acute exacerbation of their respiratory compromise due to hypersensitivity reactions.

A Hunter Outcome Survey has been established in order to understand better the variability and progression of Hunter syndrome (MPS II) in the population as a whole, and to monitor and evaluate long-term treatment effects of ELAPRASE. Patients and their physicians are encouraged to participate in this program. For more information, call Shire Human Genetic Therapies, Inc. at 1-866-888-0660.

Elaprase Is Manufactured By: 

Shire Human Genetic Therapies, Inc.
300 Shire Way
Lexington, MA 02421
US License Number 1593
Phone # 1-866-888-0660

ELAPRASE is a registered trademark of Shire Human Genetic Therapies, Inc.

Your use of this website constitutes your agreement to the terms and conditions linked below:
Terms and Conditions | Resources
2017 © Copyright PharmacyHQ.com. Questions?
Please contact: phq.contact@gmail.com